| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $214K | -90.9% | -40.4% |
| Cost of Revenue | $4.9M | -33.8% | -61.2% |
| Gross Profit | -$4.7M | +7.4% | +61.8% |
| R&D Expense | $1.0M | -27.9% | -61.7% |
| SG&A Expense | $3.7M | -0.8% | -39.2% |
| Operating Income | -$9.8M | +15.1% | +58.6% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.5M | +344.0% | -72.4% |
| Accounts Receivable | $108K | -27.0% | -73.8% |
| Inventory | $4.7M | -0.4% | -33.9% |
| Current Assets | $11.6M | +3.5% | -83.1% |
| Total Assets | $36.1M | -8.8% | -62.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$36.4M | — | — |
| Capital Expenditures | $1.1M | — | — |
| Investing Cash Flow | $17.3M | — | — |
| Financing Cash Flow | $8.9M | — | — |
| Free Cash Flow | -$37.5M | — | — |
| — |
| — |
| Net Income | -$10.4M | +6.2% | +53.9% |
| EPS (Basic) | -$0.73 | +18.9% | +61.6% |
| EPS (Diluted) | -$0.73 | +18.9% | +61.6% |
| $23.8M |
| -0.6% |
| -25.8% |
| Total Liabilities | $37.9M | +4.4% | -20.2% |
| Stockholders' Equity | -$1.8M | -153.5% | -103.6% |